Business Wire

Mayo Clinic and PN Medical Publish Study that Shows How to Reduce Stress and Anxiety

An 18% reduction in stress was one of the most significant outcomes. ORLANDO, Fla.--(BUSINESS WIRE)--Mayo Clinic released the results of a clinical trial demonstrating the positive outcomes of a ...
Yahoo Finance

PN Medical Launches First-of-Its-Kind Study to Show Direct Impact of Respiratory Muscle Training

Orlando, Florida--(Newsfile Corp. - October 6, 2023) - PN Medical, a cardiopulmonary device manufacturer developing combined respiratory muscle training (cRMT) devices, today announced that it has ...
Yahoo Finance

Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis

HAMPTON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the first patient has been dosed in the Company’s Phase 2 subcutaneous study of ...
MM&M

AstraZeneca and Ionis’ ATTRv-PN drug eplontersen shows promise in Phase III study

Ionis Pharmaceuticals and AstraZeneca unveiled promising Phase III results for the ATTR drug eplontersen, showing it met all of its co-primary endpoints and secondary endpoints compared to a placebo ...
Nasdaq

Protagonist (PTGX) Begins Dosing in Phase I Study With PN-235

Protagonist Therapeutics, Inc. PTGX announced that it has dosed the first patient in a phase I study, evaluating its oral interleukin-23 receptor (IL-23R) antagonist peptide – PN-235 (also known as ...